• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长效胰岛素类似物甘精胰岛素高剂量在2型糖尿病患者基础-餐时胰岛素治疗中的疗效

Efficacy of long-acting insulin analog insulin glargine at high dosage for basal-bolus insulin therapy in patients with type 2 diabetes.

作者信息

Suzuki Daisuke, Toyoda Masao, Kondo Masumi, Miyatake Han, Tanaka Eitaro, Sato Hiroki, Kuriyama Yusuke, Miyauchi Masaaki, Yamamoto Naoyuki, Kimura Moritsugu, Umezono Tomoya, Fukagawa Masafumi

机构信息

Division of Nephrology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193 Japan.

出版信息

Tokai J Exp Clin Med. 2012 Jul 20;37(2):35-40.

PMID:22763825
Abstract

OBJECTIVE

Attempts to achieve strict glycemic control with basal-bolus insulin therapy required increased dosages of neutral protamine Hagedorn (NPH) insulin. However, high dosage of NPH insulin often occurs nocturnal hypoglycemia. Insulin glargine can simulate normal basal insulin secretion with its flat time-action profiles. To confirm the efficacy of insulin glargine we investigated the type 2 diabetic patients on basal-bolus insulin therapy whose basal insulin was switched from NPH insulin to insulin glargine.

METHODS

The Japanese 400 patients with type 2 diabetes on basal-bolus insulin therapy whose basal insulin was switched from NPH insulin to insulin glargine were followed-up. After the switching, the basal insulin was increased with reference to the self-monitoring of blood glucose results, with the aim of maintaining fasting blood sugar (FBS) level at 110 mg/dL, and simultaneously reducing the bolus insulin dosage to maintain the total daily insulin dosage.

RESULTS

We were able to lower FBS significantly with almost no serious hypoglycemia. HbA1c also improved significantly. The improvements in FBS and HbA1c levels did not require a significant increase in the total insulin dosage.

CONCLUSION

Our results suggest that basal insulin supplementation using insulin glargine is a useful method to control not only FBS but also HbA1c.

摘要

目的

采用基础-餐时胰岛素疗法实现严格血糖控制时,需要增加中效胰岛素(NPH)的剂量。然而,高剂量的NPH胰岛素常引发夜间低血糖。甘精胰岛素能以其平稳的时间-作用曲线模拟正常基础胰岛素分泌。为证实甘精胰岛素的疗效,我们对基础-餐时胰岛素治疗的2型糖尿病患者进行了研究,这些患者的基础胰岛素由NPH胰岛素转换为甘精胰岛素。

方法

对400例接受基础-餐时胰岛素治疗且基础胰岛素由NPH胰岛素转换为甘精胰岛素的日本2型糖尿病患者进行随访。转换后,根据自我血糖监测结果增加基础胰岛素剂量,目标是将空腹血糖(FBS)水平维持在110mg/dL,同时减少餐时胰岛素剂量以维持每日胰岛素总剂量。

结果

我们能够显著降低FBS,且几乎没有严重低血糖发生。糖化血红蛋白(HbA1c)也显著改善。FBS和HbA1c水平的改善并不需要显著增加胰岛素总剂量。

结论

我们的结果表明,使用甘精胰岛素补充基础胰岛素不仅是控制FBS,也是控制HbA1c的有效方法。

相似文献

1
Efficacy of long-acting insulin analog insulin glargine at high dosage for basal-bolus insulin therapy in patients with type 2 diabetes.长效胰岛素类似物甘精胰岛素高剂量在2型糖尿病患者基础-餐时胰岛素治疗中的疗效
Tokai J Exp Clin Med. 2012 Jul 20;37(2):35-40.
2
Insulin glargine improves glycemic control and quality of life in type 2 diabetic patients on hemodialysis.甘精胰岛素可改善血液透析的 2 型糖尿病患者的血糖控制和生活质量。
J Nephrol. 2012 Nov-Dec;25(6):989-95. doi: 10.5301/jn.5000081.
3
Comparison of safety and efficacy of insulin glargine and neutral protamine hagedorn insulin in older adults with type 2 diabetes mellitus: results from a pooled analysis.比较甘精胰岛素和中性鱼精蛋白锌胰岛素在老年 2 型糖尿病患者中的安全性和疗效:一项汇总分析的结果。
J Am Geriatr Soc. 2012 Jan;60(1):51-9. doi: 10.1111/j.1532-5415.2011.03773.x.
4
Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetes.使用低血糖敏感算法调整胰岛素剂量滴定:初治2型糖尿病患者中甘精胰岛素与低精蛋白锌胰岛素的比较
Diabetes Obes Metab. 2015 Jan;17(1):15-22. doi: 10.1111/dom.12329. Epub 2014 Jul 12.
5
Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1.2).在日本糖尿病患者中,从NPH胰岛素转换为甘精胰岛素作为基础胰岛素强化替代治疗后的长期疗效。1型和2型糖尿病疗效比较(JUN-LAN研究1.2)
Endocr J. 2007 Dec;54(6):975-83. doi: 10.1507/endocrj.k07e-035. Epub 2007 Nov 14.
6
Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial.格列美脲联合甘精胰岛素早晨注射、低精蛋白锌胰岛素睡前注射或甘精胰岛素睡前注射用于2型糖尿病患者。一项随机对照试验。
Ann Intern Med. 2003 Jun 17;138(12):952-9. doi: 10.7326/0003-4819-138-12-200306170-00006.
7
Insulin Glargine U100 Improved Glycemic Control and Reduced Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3 and 4.精氨酸胰岛素 U100 改善 2 型糖尿病伴慢性肾脏病 3 期和 4 期患者的血糖控制并减少夜间低血糖。
Clin Ther. 2019 Oct;41(10):2008-2020.e3. doi: 10.1016/j.clinthera.2019.07.011. Epub 2019 Aug 2.
8
Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes.在1型糖尿病患者中,甘精胰岛素与中性鱼精蛋白锌胰岛素相比,可降低空腹血糖、血糖变异性和夜间低血糖。
Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):571-9. doi: 10.1016/j.numecd.2008.05.003. Epub 2008 Aug 3.
9
Outcomes with insulin glargine in patients with type 2 diabetes previously on NPH insulin: evidence from clinical practice in Spain.在先前使用 NPH 胰岛素的 2 型糖尿病患者中使用甘精胰岛素的结果:来自西班牙临床实践的证据。
Int J Clin Pract. 2012 Mar;66(3):281-8. doi: 10.1111/j.1742-1241.2011.02880.x.
10
Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus.在11项关于甘精胰岛素与中性鱼精蛋白锌胰岛素治疗1型和2型糖尿病的III期和IV期研究中,对糖化血红蛋白和低血糖结局合并数据进行的负二项式meta回归分析。
Clin Ther. 2007 Aug;29(8):1607-19. doi: 10.1016/j.clinthera.2007.08.020.

引用本文的文献

1
Factors influencing insulin requirements in using continuous subcutaneous insulin infusion or multiple daily injections in type 2 diabetes.2型糖尿病患者使用持续皮下胰岛素输注或多次皮下注射时影响胰岛素需求量的因素
World J Diabetes. 2025 Jul 15;16(7):106470. doi: 10.4239/wjd.v16.i7.106470.
2
Use of Insulin Glargine 100 U/mL for the Treatment of Type 2 Diabetes Mellitus in East Asians: A Review.甘精胰岛素100 U/mL用于东亚2型糖尿病治疗的综述
Diabetes Ther. 2019 Jun;10(3):805-833. doi: 10.1007/s13300-019-0613-7. Epub 2019 Apr 24.
3
New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2).
在使用基础胰岛素和口服降糖药的日本2型糖尿病患者中,新型甘精胰岛素300 U/ml与甘精胰岛素100 U/ml的比较:一项随机对照试验(EDITION JP 2)中的血糖控制和低血糖情况
Diabetes Obes Metab. 2016 Apr;18(4):366-74. doi: 10.1111/dom.12618. Epub 2016 Jan 21.
4
Drug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysis.观察性研究中与药物相关的严重低血糖风险:一项系统评价和荟萃分析。
BMC Endocr Disord. 2015 Oct 12;15:57. doi: 10.1186/s12902-015-0052-z.
5
Comparison of continuous subcutaneous insulin infusion and insulin glargine-based multiple daily insulin aspart injections with preferential adjustment of basal insulin in patients with type 2 diabetes.2型糖尿病患者中持续皮下胰岛素输注与基于甘精胰岛素的多次门冬胰岛素注射并优先调整基础胰岛素的比较。
Exp Ther Med. 2014 Oct;8(4):1191-1196. doi: 10.3892/etm.2014.1866. Epub 2014 Jul 29.
6
Identifying and meeting the challenges of insulin therapy in type 2 diabetes.识别并应对 2 型糖尿病胰岛素治疗的挑战。
J Multidiscip Healthc. 2014 Jul 2;7:267-82. doi: 10.2147/JMDH.S64084. eCollection 2014.
7
Insulin glargine effectively achieves glycemic control and improves insulin resistance in patients with early type 2 diabetes that exhibit a high risk for cardiovascular disease.甘精胰岛素能有效实现血糖控制,并改善有心血管疾病高风险的早期2型糖尿病患者的胰岛素抵抗。
Exp Ther Med. 2014 Jul;8(1):147-152. doi: 10.3892/etm.2014.1688. Epub 2014 Apr 24.